Where Medicare’s $35 monthly insulin cap could mean big savings
The Inflation Reduction Act capped the monthly out-of-pocket cost of insulin at $35 for Medicare Part D subscribers on Jan. 1. Starting July 1, Medicare Part B enrollees will also have a $35 cap per monthly prescription. Among people who use insulin, about 52 percent of them are Medicare beneficiaries, according to HHS.
Fill out the form to access this premium content.